A detailed history of National Pension Service transactions in Legend Biotech Corp stock. As of the latest transaction made, National Pension Service holds 23,535 shares of LEGN stock, worth $942,106. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,535
Previous 22,574 4.26%
Holding current value
$942,106
Previous $999,000 14.71%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$43.55 - $59.88 $41,851 - $57,544
961 Added 4.26%
23,535 $1.15 Million
Q1 2024

May 13, 2024

BUY
$55.06 - $69.99 $244,686 - $311,035
4,444 Added 24.51%
22,574 $1.27 Million
Q3 2023

Nov 14, 2023

SELL
$63.16 - $76.5 $199,396 - $241,510
-3,157 Reduced 14.83%
18,130 $1.22 Million
Q2 2023

Aug 15, 2023

BUY
$46.28 - $75.01 $253,151 - $410,304
5,470 Added 34.58%
21,287 $1.47 Million
Q1 2023

May 11, 2023

BUY
$43.42 - $57.37 $263,819 - $348,580
6,076 Added 62.38%
15,817 $762,000
Q4 2022

Feb 23, 2023

SELL
$38.8 - $55.46 $29,681 - $42,426
-765 Reduced 7.28%
9,741 $486,000
Q4 2022

Feb 17, 2023

SELL
$38.8 - $55.46 $29,681 - $42,426
-765 Reduced 7.28%
9,741 $486,000
Q3 2022

Feb 23, 2023

BUY
$38.15 - $57.1 $29,184 - $43,681
765 Added 7.85%
10,506 $428,000
Q3 2022

Nov 17, 2022

BUY
$38.15 - $57.1 $210,359 - $314,849
5,514 Added 110.46%
10,506 $421,000
Q2 2022

Aug 17, 2022

BUY
$33.54 - $55.0 $135,769 - $222,640
4,048 Added 428.81%
4,992 $275,000
Q4 2021

Feb 15, 2022

BUY
$41.14 - $56.98 $38,836 - $53,789
944 New
944 $44,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track National Pension Service Portfolio

Follow National Pension Service and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Pension Service, based on Form 13F filings with the SEC.

News

Stay updated on National Pension Service with notifications on news.